Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Pedro Zubizarreta"'
Autor:
Lorena V. Baroni, Nicolas Fernández Ponce, Candela Freytes, Francisco R. Maldonado, Natalia Pinto, Javier González Ramos, Fabiana Lubieniecki, Pedro Zubizarreta, Daniel Alderete
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/f0b853c9aaf14068bbb2e69df8e81e0f
Autor:
Natalia Riva, Manuel Molina, Berta L. Cornaló, María V. Salvador, Andrea Savransky, Silvia Tenembaum, María M. Katsicas, Marta Monteverde, Paulo Cáceres Guido, Marcela Rousseau, Raquel Staciuk, Agustín González Correas, Pedro Zubizarreta, Oscar Imventarza, Eduardo Lagomarsino, Eduardo Spitzer, Marcelo Tinelli, Paula Schaiquevich
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Although rituximab is widely used off-label for complex pediatric diseases, safety reports are limited. We aimed to report evidence of its use in clinical practice, to describe the incidence of adverse drug reactions (ADR) to rituximab biosimilar Nov
Externí odkaz:
https://doaj.org/article/805357f7b1074ce3885912fd103b3cee
Autor:
J. Lopez Marti, M. Ramos, Pedro Zubizarreta, E. Rossetti, Gabriela Gonzalez Diaz, Walter Cacciavillano, Adriana Rose, M. Viso, G. Felizzia, Sergio Innocenti
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 6, Iss 4, Pp 175-185 (2021)
Background Synovial sarcoma (SS) is characterized by local invasiveness and a propensity to develop distant metastases. Current treatment for pediatric patients is based on the strategy used by the two main international groups, the Children's Oncolo
Autor:
Pedro Zubizarreta
Publikováno v:
Journal of Public Health International. 6:16-17
Autor:
Gabriela Villanueva, Claudia Sampor, Florencia Moreno, Daniel Alderete, Angelica Moresco, Natalia Pinto, Irene Szijan, Paula Schaiquevich, María Sara Felice, Adriana Rose, Pedro Zubizarreta, Mariana Sgroi, Adriana Fandiño, Guillermo Chantada
Publikováno v:
Pediatric Blood & Cancer. 69
Retinoblastoma survivors in low- and middle-income countries are exposed to high-intensity treatments that potentially place them at higher risk of early subsequent malignant neoplasms (SMNs).We followed 714 (403 [56.4%] nonhereditary and 311 [43.5%]
Autor:
Daniela Fortunati, Julio Kaplan, Jessica López Martí, Agustina Ponzone, Sergio Innocenti, Silvina Fiscina, Walter Cacciavillano, Pedro Zubizarreta, Adriana Rose
Publikováno v:
Medicina (Buenos Aires), Vol 80, Iss 5, Pp 495-504 (2020)
Desmoid-type fibromatosis (DF) is a tumor with high local recurrence rate. Sixteen patients (18 desmoid tumors) were retrospectively evaluated. Initial surgery was performed in 13/18 tumors, with complete resection in 6 (one with free margin and five
Autor:
María Deu, María Bertone, María Felice, Luisina Peruzzo, Carla Pennella, Cristian Rosa, Myriam Guitter, Elizabeth Alfaro, Pedro Zubizarreta
Publikováno v:
Medical Research Archives. 10
Spinal cord compression (SCC) is an unusual manifestation of leukemias and lymphomas in children and defines an oncological emergency frequently unsuspected, being a cause of severe sequelae. Our aim was to analyze the characteristics of patients who
Publikováno v:
Archivos Argentinos de Pediatria. 119
Although colorectal carcinoma (CRC) is the third most common type of cancer in adults, only 1-4 % of cases are reported in individuals younger than 25-30 years. Its presentation is usually confused with other diseases, leading to significant delays i
Autor:
Natalia, Riva, Manuel, Molina, Berta L, Cornaló, María V, Salvador, Andrea, Savransky, Silvia, Tenembaum, María M, Katsicas, Marta, Monteverde, Paulo, Cáceres Guido, Marcela, Rousseau, Raquel, Staciuk, Agustín, González Correas, Pedro, Zubizarreta, Oscar, Imventarza, Eduardo, Lagomarsino, Eduardo, Spitzer, Marcelo, Tinelli, Paula, Schaiquevich
Publikováno v:
Frontiers in pharmacology. 12
Although rituximab is widely used off-label for complex pediatric diseases, safety reports are limited. We aimed to report evidence of its use in clinical practice, to describe the incidence of adverse drug reactions (ADR) to rituximab biosimilar Nov
Autor:
Natalia Pinto, Lorena V Baroni, Claudia Sampor, Carlos Rugilo, Agustina Oller, Nicolas Ponce Fernandez, Pedro Zubizarreta, Daniel Alderete, Fabiana Lubieniecki, Candela Freytes
Background: Intracranial germ cell tumor (iGCT) represents a rare and heterogeneous group, with variable incidence and diverse treatment strategies. Although multiagent chemotherapy with reduced radiotherapy strategy has been applied by several coope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::349fa1af4a09a26164bdc758f8822692
https://doi.org/10.21203/rs.3.rs-157912/v1
https://doi.org/10.21203/rs.3.rs-157912/v1